David Soler

Psoriasis patients exhibit impairment of the high potency CCR5+ T regulatory cell subset

David Soler, Hideaki Sugiyama, A. B. Young et al. · Clinical Immunology · 2013 · 58 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Psoriasis and cardiovascular risk factors: increased serum myeloperoxidase and corresponding immunocellular overexpression by Cd11b(+) CD68(+) macrophages in skin lesions.

Lauren Cao, David Soler, S. Debanne et al. · PubMed · 2013 · 38 citations

Medicine, Immunology, Pathology +17

Increased, but Functionally Impaired, CD14+ HLA-DR–/low Myeloid-Derived Suppressor Cells in Psoriasis: A Mechanism of Dysregulated T Cells

David Soler, A. B. Young, Lori Fiessinger et al. · Journal of Investigative Dermatology · 2016 · 37 citations

Life Sciences, Dermatology, Immunology +12

The key role of aquaporin 3 and aquaporin 10 in the pathogenesis of pompholyx

David Soler, Xuefan Bai, Liliana Ortega et al. · Medical Hypotheses · 2015 · 35 citations

Medicine, Molecular Genetics, Pathology +7

Radiation sensitivity increases with proliferation‐associated telomere dysfunction in nontransformed human epithelial cells

David Soler, Judit Pampalona, Laura Tusell et al. · Aging Cell · 2009 · 29 citations

Medicine, Cancer Biology, Oncology +17